Literature DB >> 10731226

Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex.

N D Volkow1, J S Fowler.   

Abstract

Understanding the changes in the brain which occur in the transition from normal to addictive behavior has major implications in public health. Here we postulate that while reward circuits (nucleus accumbens, amygdala), which have been central to theories of drug addiction, may be crucial to initiate drug self-administration, the addictive state also involves disruption of circuits involved with compulsive behaviors and with drive. We postulate that intermittent dopaminergic activation of reward circuits secondary to drug self-administration leads to dysfunction of the orbitofrontal cortex via the striato-thalamo-orbitofrontal circuit. This is supported by imaging studies showing that in drug abusers studied during protracted withdrawal, the orbitofrontal cortex is hypoactive in proportion to the levels of dopamine D2 receptors in the striatum. In contrast, when drug abusers are tested shortly after last cocaine use or during drug-induced craving, the orbitofrontal cortex is hypermetabolic in proportion to the intensity of the craving. Because the orbitofrontal cortex is involved with drive and with compulsive repetitive behaviors, its abnormal activation in the addicted subject could explain why compulsive drug self-administration occurs even with tolerance to the pleasurable drug effects and in the presence of adverse reactions. This model implies that pleasure per se is not enough to maintain compulsive drug administration in the drugaddicted subject and that drugs that could interfere with the activation of the striato-thalamo-orbitofrontal circuit could be beneficial in the treatment of drug addiction.

Entities:  

Mesh:

Year:  2000        PMID: 10731226     DOI: 10.1093/cercor/10.3.318

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  381 in total

Review 1.  Neuropsychiatry of the basal ganglia.

Authors:  H A Ring; J Serra-Mestres
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-01       Impact factor: 10.154

2.  Addiction changes orbitofrontal gyrus function: involvement in response inhibition.

Authors:  R Z Goldstein; N D Volkow; G J Wang; J S Fowler; S Rajaram
Journal:  Neuroreport       Date:  2001-08-08       Impact factor: 1.837

3.  Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuse.

Authors:  E Lehrmann; J Oyler; M P Vawter; T M Hyde; B Kolachana; J E Kleinman; M A Huestis; K G Becker; W J Freed
Journal:  Pharmacogenomics J       Date:  2003       Impact factor: 3.550

4.  The orbitofrontal cortex in methamphetamine addiction: involvement in fear.

Authors:  Rita Z Goldstein; Nora D Volkow; Linda Chang; Gene-Jack Wang; Joanna S Fowler; Richard A Depue; Ruben C Gur
Journal:  Neuroreport       Date:  2002-12-03       Impact factor: 1.837

5.  Neurofunctional Domains Derived From Deep Behavioral Phenotyping in Alcohol Use Disorder.

Authors:  Laura E Kwako; Melanie L Schwandt; Vijay A Ramchandani; Nancy Diazgranados; George F Koob; Nora D Volkow; Carlos Blanco; David Goldman
Journal:  Am J Psychiatry       Date:  2019-01-04       Impact factor: 18.112

6.  Environmental enrichment facilitates cocaine-cue extinction, deters reacquisition of cocaine self-administration and alters AMPAR GluA1 expression and phosphorylation.

Authors:  Jamie M Gauthier; Amy Lin; Bríd Á Nic Dhonnchadha; Roger D Spealman; Heng-Ye Man; Kathleen M Kantak
Journal:  Addict Biol       Date:  2015-09-18       Impact factor: 4.280

Review 7.  Obesity and Brain Positron Emission Tomography.

Authors:  Kyoungjune Pak; Seong-Jang Kim; In Joo Kim
Journal:  Nucl Med Mol Imaging       Date:  2017-05-19

Review 8.  The role of orbitofrontal cortex in drug addiction: a review of preclinical studies.

Authors:  Geoffrey Schoenbaum; Yavin Shaham
Journal:  Biol Psychiatry       Date:  2007-08-23       Impact factor: 13.382

9.  Reduced connexin 43 immunolabeling in the orbitofrontal cortex in alcohol dependence and depression.

Authors:  José Javier Miguel-Hidalgo; Barbara A Wilson; Syed Hussain; Ashish Meshram; Grazyna Rajkowska; Craig A Stockmeier
Journal:  J Psychiatr Res       Date:  2014-04-16       Impact factor: 4.791

10.  Developmental Trajectories of the Orbitofrontal Cortex and Anhedonia in Middle Childhood and Risk for Substance Use in Adolescence in a Longitudinal Sample of Depressed and Healthy Preschoolers.

Authors:  Joan L Luby; Arpana Agrawal; Andy Belden; Diana Whalen; Rebecca Tillman; Deanna M Barch
Journal:  Am J Psychiatry       Date:  2018-03-21       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.